Looking Forward: The Next Generation of Bio similars February 7, 2017 12:00 PM Description Many of today’s important medications are biological products made from living organisms, manufactured through biotechnology, derived from natural sources, or produced synthetically. Biosimilars are a type of biological product approved by FDA on the basis of being highly similar to an…
Looking Forward: The Next Generation of Bio similars February 7, 2017 12:00 PM Description Many of today’s important medications are biological products made from living organisms, manufactured through biotechnology, derived from natural sources, or produced synthetically. Biosimilars are a type of biological product approved by FDA on the basis of being highly similar to an…
Health Law Year in P/Review Featured Panel: The End of ObamaCare? Health Care Reform Under A New Administration January 23, 2017 Wasserstein Hall, Milstein West AB Harvard Law School, 1585 Massachusetts Ave., Cambridge, MA Register for this event The Fifth Annual Health Law Year in P/Review symposium will feature leading experts discussing major developments during…
Health Law Year in P/Review Featured Panel: The End of ObamaCare? Health Care Reform Under A New Administration January 23, 2017 Wasserstein Hall, Milstein West AB Harvard Law School, 1585 Massachusetts Ave., Cambridge, MA Register for this event The Fifth Annual Health Law Year in P/Review symposium will feature leading experts discussing major developments during…
By Rachel Sachs Yesterday, a federal district judge made an important ruling in the ongoing patent dispute between Amgen’s cholesterol-lowering drug Repatha and Sanofi and Regeneron’s drug, Praluent. Early in 2016, Amgen’s patents covering the products had been found both valid and infringed, and now Judge Sue Robinson has granted Amgen’s request for an injunction…
Health Law Year in P/Review Featured Panel: The End of ObamaCare? Health Care Reform Under A New Administration January 23, 2017 Wasserstein Hall, Milstein West AB Harvard Law School, 1585 Massachusetts Ave., Cambridge, MA Register for this event The Fifth Annual Health Law Year in P/Review symposium will feature leading experts discussing major developments during…
Webinar: President-Elect Trump’s Health Policy Agenda: Priorities, Strategies, and Predictions Monday, December 19, 2016, 12:00 – 1:00pm WATCH LIVE ONLINE!: https://petrieflom.law.harvard.edu/events/details/president-elect-trumps-health-policy-agenda Submit your questions to the panelists via Twitter @PetrieFlom. Please join the Petrie-Flom Center for a live webinar to address what health care reform may look like under the new administration. Expert panelists will…
By Seán Finan After several failed attempts, years of protracted negotiations and a glacial ratification process, it seemed as if Brexit would finally put an end to the nascent European Unitary Patent. Last week, however, the UK confirmed its intention to ratify the Unified Patent Court Agreement and to move forward with the plans for the…
Health Law Year in P/Review Featured Panel: The End of ObamaCare? Health Care Reform Under A New Administration January 23, 2017 Wasserstein Hall, Milstein West AB Harvard Law School, 1585 Massachusetts Ave., Cambridge, MA Register for this event The Fifth Annual Health Law Year in P/Review symposium will feature leading experts discussing major developments during…
By Seán Finan And scattered about it, some in their overturned war-machines, some in the now rigid handling-machines, and a dozen of them stark and silent and laid in a row, were the Martians–dead!–slain by the putrefactive and disease bacteria against which their systems were unprepared; slain as the red weed was being slain; slain,…
